Cannasouth is a biopharmaceutical research and development company based across Waikato and the Bay of Plenty. The Company has been established to focus on the commercial development of the medicinally beneficial attributes of cannabinoid compounds such as CBD, THC and associated chemical structures that are produced by the cannabis plant. Our goal is the development of next-generation cannabinoid medicines that support patients’ health outcomes and improve their quality of life. Our products will be produced under GMP & ISO using environmentally friendly methods without the use of harmful chemicals or solvents, ensuring patients are treated with pure cannabinoid therapeutic compounds of the highest quality.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 2 Melody Lane, Hamilton East, Crv Building,waikato Innovation Park,new Zealand
- Phone
- 64 (0)7 949 8393
- en****@****h.co.nz
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cannasouth.co.nz
- Keywords
- Kekerengu.
- HQ
- Hamilton, Waikato
Cannasouth Bioscience Limited Questions
Cannasouth Bioscience Limited's helpline number is 64 (0)7 949 8393
Cannasouth Bioscience Limited's website is cannasouth.co.nz
Cannasouth Bioscience Limited's LinkedIn profile is https://nz.linkedin.com/company/cannasouth
Cannasouth Bioscience Limited has
10 employees.
View email and phone details for 10
employees at Cannasouth Bioscience Limited.
Cannasouth Bioscience Limited's industry is
Biotechnology Research
Cannasouth Bioscience Limited's top competitors are
Puro New Zealand,
New Zealand Medicinal Cannabis Council,
Kāriki Pharma,
Gmp Pharmaceuticals Ltd,
Nubu,
Greenfern Industries,
Helius Therapeutics,
Rua Bioscience,
Eqalis,
Ora Pharm.
Cannasouth Bioscience Limited's support email address is enquiries@cannasouth.co.nz
Cannasouth Bioscience Limited's categories are Biotechnology Research
Cannasouth Bioscience Limited's founding year is 2017
